CYP450 3A4/5 Containment During SARS‐CoV‐2 Infection

Clinical Pharmacology & TherapeuticsVolume 113, Issue 2 p. 218-218 Letter to the Editor CYP450 3A4/5 Containment During SARS-CoV-2 Infection Jean Terrier, Corresponding Author Jean Terrier jean.terrier@hcuge.ch orcid.org/0000-0002-5878-4878 Clinical Pharmacology and Toxicology Service, Anesthesiology, Pharmacology and Intensive Care Department, Geneva University Hospitals, Geneva, Switzerland Division of General Internal Medicine, Geneva University Hospitals, Geneva, SwitzerlandCorrespondence: Jean Terrier (jean.terrier@hcuge.ch)Search for more papers by this authorCamille Lenoir, Camille Lenoir orcid.org/0000-0001-6506-8629 Clinical Pharmacology and Toxicology Service, Anesthesiology, Pharmacology and Intensive Care Department, Geneva University Hospitals, Geneva, SwitzerlandSearch for more papers by this authorCaroline Samer, Caroline Samer orcid.org/0000-0001-8178-0616 Clinical Pharmacology and Toxicology Service, Anesthesiology, Pharmacology and Intensive Care Department, Geneva University Hospitals, Geneva, SwitzerlandSearch for more papers by this author Jean Terrier, Corresponding Author Jean Terrier jean.terrier@hcuge.ch orcid.org/0000-0002-5878-4878 Clinical Pharmacology and Toxicology Service, Anesthesiology, Pharmacology and Intensive Care Department, Geneva University Hospitals, Geneva, Switzerland Division of General Internal Medicine, Geneva University Hospitals, Geneva, SwitzerlandCorrespondence: Jean Terrier (jean.terrier@hcuge.ch)Search for more papers by this authorCamille Lenoir, Camille Lenoir orcid.org/0000-0001-6506-8629 Clinical Pharmacology and Toxicology Service, Anesthesiology, Pharmacology and Intensive Care Department, Geneva University Hospitals, Geneva, SwitzerlandSearch for more papers by this authorCaroline Samer, Caroline Samer orcid.org/0000-0001-8178-0616 Clinical Pharmacology and Toxicology Service, Anesthesiology, Pharmacology and Intensive Care Department, Geneva University Hospitals, Geneva, SwitzerlandSearch for more papers by this author First published: 08 September 2022 https://doi.org/10.1002/cpt.2725Citations: 1 Linked article: This article is linked to, Response to “CYP450 3A4/5 Containment During SARS-CoV-2 Infection” by Le Carpentier, E.C. et al. Clin. Pharmacol. Ther. 113, 219–220 (2023). https://doi.org/10.1002/cpt.2726 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume113, Issue2February 2023Pages 218-218 This article also appears in:COVID-19 in ASCPT RelatedInformation